Nucleoprotein machines carry out essential biological processes including synthesis, modification, and repair of DNA and RNA. We propose to establish a nanomedicine development center (NDC) focusing on a model nanomachine that carries out nonhomologous end joining (NHEJ) of DNA double strand breaks. This and other DNA repair machines have relatively simple structures (<20 components) and significant biological and clinical relevance. DNA damage repair is vitally important to human health, as both normal metabolic activities and environmental factors can cause DNA damage, resulting in as many as 100,000 individual molecular lesions per cell per day. If allowed to accumulate without repair, these lesions interfere with gene transcription and replication, leading to premature aging, apoptosis, or unregulated cell division. We have assembled an interdisciplinary team from eight institutions, with significant expertise in cell and molecular biology of DNA damage repair, protein tagging and targeting, nanostructured probes, cryo-electron microscopy, signal-cell imaging, quantitative image analysis and computational biology, and light microscopy instrumentation. We will develop innovative nanotechnologies and biomolecular approaches to elucidate the structure-function relationships within and among DNA repair nanomachines. General principles emerging from these studies will lay a foundation for precise modification of the information stored in DNA and RNA, leading ultimately to novel therapeutic strategies for a wide range of diseases, including cancer. The NDC has five closely related aims including: (1) to develop orthogonal protein tagging strategies and novel fluorescence probes including quantum dot bioconjugates for nanomachine targeting;(2) to decipher structure-function relationship of components required for the core NHEJ reaction;(3) to characterize the dynamics of nanomachine assembly and disassembly in the context of repair foci;(4) to determine the dimensions and structure of repair foci at high resolution in fixed cells;(5) to establish the engineering design principles underlying DNA double-strand break repair. This NDC will complement existing NDCs that focus on filaments, membranes and protein folding enzymes, and the probes, tools and methodologies developed will be applicable to a wide range of biological and disease studies. Our long-term vision is to provide genetic cures for common human diseases based on the ability to manipulate the somatic human genome using nanomedicine approaches that are inexpensive, effective, and user-friendly, similar to vaccination today.

National Institute of Health (NIH)
National Eye Institute (NEI)
Research Development Center (PN2)
Project #
Application #
Study Section
Special Emphasis Panel (ZEY1-VSN (20))
Program Officer
Fisher, Richard S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgia Institute of Technology
Engineering (All Types)
Schools of Engineering
United States
Zip Code
Jarrett, Kelsey E; Lee, Ciaran M; Yeh, Yi-Hsien et al. (2017) Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease. Sci Rep 7:44624
Lee, Ciaran M; Cradick, Thomas J; Bao, Gang (2016) The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells. Mol Ther 24:645-54
Tabebordbar, Mohammadsharif; Zhu, Kexian; Cheng, Jason K W et al. (2016) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351:407-411
Chew, Wei Leong; Tabebordbar, Mohammadsharif; Cheng, Jason K W et al. (2016) A multifunctional AAV-CRISPR-Cas9 and its host response. Nat Methods 13:868-74
Porteus, Matthew (2016) Genome Editing: A New Approach to Human Therapeutics. Annu Rev Pharmacol Toxicol 56:163-90
Cottle, Renee N; Lee, Ciaran M; Bao, Gang (2016) Treating hemoglobinopathies using gene-correction approaches: promises and challenges. Hum Genet 135:993-1010
Rowe, R Grant; Wang, Leo D; Coma, Silvia et al. (2016) Developmental regulation of myeloerythroid progenitor function by the Lin28b-let-7-Hmga2 axis. J Exp Med 213:1497-512
Müller, Maximilian; Lee, Ciaran M; Gasiunas, Giedrius et al. (2016) Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome. Mol Ther 24:636-44
Park, Seonhee; Choi, Seong-O; Paik, Seung-joon et al. (2016) Intracellular delivery of molecules using microfabricated nanoneedle arrays. Biomed Microdevices 18:10
Porteus, Matthew H (2015) Genome Editing of the Blood: Opportunities and Challenges. Curr Stem Cell Rep 1:23-30

Showing the most recent 10 out of 87 publications